Biomarkers (biological markers) are biological measures of a biological state. The most generic definition of biomarkers is based on their role as descriptors or measures of biological systems. Biomarkers are used to diagnose and drug development, as they indicate diseases in the body. Moreover, biomarker-based test are precise and rapid, which in turn help in early prediction of diagnosis, prognosis, susceptibility, and treatment of disease. Biomarkers are also used for drug discovery and development purpose.
Request for Sample Report @
Government immunization programs and introduction of novel products are expected to drive growth of the global biomarkers market during the forecast period. Players in the market are focusing on developing and launching novel products For instance, in March 2017, GeneNews Limited announced the launch of BreastSentry, a new risk stratification test for breast cancer, via its Virginia-based clinical reference lab, Innovative Diagnostics Laboratory. BreastSentry incorporates a blood-based biomarker test with an algorithm to determine a woman’s five-year and lifetime risk for developing breast cancer.
Moreover, in February 2018, Genomic Health, Inc. launched the Oncotype DX AR-V7 Nucleus Detect test. The first and only liquid biopsy test of its kind, the Oncotype DX AR-V7 Nucleus Detect test was developed by Epic Sciences to help prolong the lives of men with metastatic castration-resistant prostate cancer (mCRPC) by accurately detecting a splice variant of the androgen receptor protein (AR-V7) in the nucleus of circulating tumor cells (CTCs).
In May 2017, MilliporeSigma announced the launch of their new Single Molecule Counting Platform, termed SMCxPROTM. SMCxPRO platform allows for a highly precise and sensitive method to both detect & quantify proteins that traditional methods cannot measure. This novel technology could enable researchers to detect or monitor changes in biomarkers at extremely low concentrations, down to a femtogram level, with scope to increase the limit of detection with further fine tuning down the line.
North America is expected to witness robust growth in the global biomarkers market due to the favorable government initiatives and increase in focus on the development of novel techniques in this region. For instance, in 2015, U.S. government launched Precision Medicine Initiative (PMI) to raise awareness and focus on advancements in precision medicine field, which in turn, favors growth of the biomarkers market.
Moreover, in 2009, FDA established Biomarker Qualification Program to support the Center for Drug Evaluation and Research’s work with external stakeholders to develop biomarkers to help in drug development process.
Get PDF Brochure With Latest Insights @
Key players active in the global biomarkers market are Lifesign LLC, Qiagen N.V., Nexus-DX, Seimens Healthnineers, BG Medicine, Inc., Medtronic, Abbott Laboratories, and F. Hoffman LA Roche Ltd. among others.
In March 2018, SenzaGen signed a strategically agreement with the well renowned Burleson Research Technologies Inc. (BRT). BRT will market and provide GARD in the United States and perform the test in its laboratory in North Carolina. BRT is the first US laboratory to offer GARD, which displays a higher accuracy than other available test methods and reveals if chemical substances are causing allergies in humans.
The following are the study objectives for this report:
✔SWOT Analysis focuses on worldwide main manufacturers to define, assess, and analyse market competition. By kind, application, and region, the market is defined, described, and forecasted.
✔Examine the global and main regional market potential and advantage, opportunity and challenge, constraints and risks.
✔Determine whether trends and factors are driving or limiting market growth.
✔By identifying high-growth categories, stakeholders would be able to analyse market potential.
✔Conduct a strategic study of each submarket’s growth trends and market contribution.
✔Expansions, agreements, new product launches, and acquisitions in the market are all examples of competitive developments.
✔To create a strategic profile of the main players and analyse their growth plans in depth.
Buy This Complete Business Report @
Table of Contents with Major Points:
1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2022-2028 (USD Billion)
1.2.1. Biomarkers Market, by Region, 2022-2028 (USD Billion)
1.2.2. Biomarkers Market, by Type, 2022-2028 (USD Billion)
1.2.3. Biomarkers Market, by Application, 2022-2028 (USD Billion)
1.2.4. Biomarkers Market, by Verticles, 2022-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
2. Global Biomarkers Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
3. Global Biomarkers Market Dynamics
3.1. Biomarkers Market Impact Analysis (2022-2028)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
4. Global Biomarkers Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2022-2028)
4.2. PEST Analysis
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
5. Global Biomarkers Market, by Type
5.1. Market Snapshot
5.2. Global Biomarkers Market by Type, Performance – Potential Analysis
5.3. Global Biomarkers Market Estimates & Forecasts by Type 2022-2028 (USD Billion)
5.4. Biomarkers Market, Sub Segment Analysis
6. Global Biomarkers Market, by Application
6.1. Market Snapshot
6.2. Global Biomarkers Market by Application, Performance – Potential Analysis
6.3. Global Biomarkers Market Estimates & Forecasts by Application 2022-2028 (USD Billion)
6.4. Biomarkers Market, Sub Segment Analysis
7. Global Biomarkers Market, by Verticles
7.1. Market Snapshot
7.2. Global Biomarkers Market by Verticles, Performance – Potential Analysis
7.3. Global Biomarkers Market Estimates & Forecasts by Verticles 2022-2028 (USD Billion)
7.4. Biomarkers Market, Sub Segment Analysis
8. Global Biomarkers Market, Regional Analysis
8.1. Biomarkers Market, Regional Market Snapshot
8.2. North America Biomarkers Market
8.3. Europe Biomarkers Market Snapshot
8.4. Asia-Pacific Biomarkers Market Snapshot
8.5. Latin America Biomarkers Market Snapshot
8.6. Rest of The World Biomarkers Market
9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
22.214.171.124. Key InDurationation
126.96.36.199. Financial (Subject to Data Availability)
188.8.131.52. Product Summary
184.108.40.206. Recent Developments
10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.3. Market Estimation
10.2. Research Attributes
Thank you for taking the time to read the research report. Kindly inform us for additional information about the customized report and customization plan, and we will provide you the most appropriate customized report.
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027